Endocannabinoids and stress

References

• Bambico FR, Gobbi G. 2008. The cannabinoid CB1 receptor and the endocannabinoid anadamide: Possible antidepressant targets. Expert Opin Ther Targets. 12:1347–1366.
   PubMed Web of Science ®Google Scholar
• Bisogno T. 2008. Endogenous cannabinoids: Structure and metabolism. J Neuroendocrinol. 20 Suppl. 1: 1–9.
   PubMed Web of Science ®Google Scholar
• Bitencourt RM, Pamplona FA, Takahashi RN. 2008. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 18:849–859.
   PubMed Web of Science ®Google Scholar
• Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ. 1995. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci. 15:61–69.
   PubMed Web of Science ®Google Scholar
• Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. 2007. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry. 62:1103–1110.
   PubMed Web of Science ®Google Scholar
• Butler RK, Finn DP. 2009. Stress-induced analgesia. Prog Neurobiol. 88:184–202.
   PubMed Web of Science ®Google Scholar
• Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL, Cuomo V. 2009. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci USA. 106:4888–4893.
   PubMed Web of Science ®Google Scholar
• Campos AC, Ferreira FR, Guimaraes FS, Lemos JI. 2010. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience. 167:238–246.
   PubMedGoogle Scholar
• Cannon W. 1935. Stresses and strains of homeostasis. Am J Med Sci. 189:1–14.
   Google Scholar
• Checkley S. 1996. The neuroendocrinology of depression and chronic stress. Br Med Bull. 52:597–617.
   PubMed Web of Science ®Google Scholar
• Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. 2005. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychophamacology. 30:516–524.
   PubMed Web of Science ®Google Scholar
• Christensen R, Kristensen PK, Bartels EM, Biddal H, Astrup A. 2007. Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomised trials. Lancet. 370:1706–1713.
   PubMed Web of Science ®Google Scholar
• Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders. J Am Med Assoc. 267:1244–1253.
   PubMed Web of Science ®Google Scholar
• Coddington E, Christine L, Rose JD, Moore FL. 2007. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology. 148:493–500.
   PubMed Web of Science ®Google Scholar
• Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:83–87.
   PubMed Web of Science ®Google Scholar
• De Boer SF, Koopmans SJ, Slangen JL, van der Gugten J. 1990. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: Effect of interstressor interval and length. Physiol Behav. 47:1117–1124.
   PubMed Web of Science ®Google Scholar
• De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D. 2010. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology. 35:374–387.
   PubMed Web of Science ®Google Scholar
• de Kloet RE, Joëls M, Holsboer F. 2005. Stress and the brain: From adaptation to disease. Nat Rev Neurosci. 6:463–475.
   PubMed Web of Science ®Google Scholar
• de Oliveira Alvares L, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, Cassini L, Molina VA, Quillfeldt JA. 2010. Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem. 17:202–209.
   PubMedGoogle Scholar
• Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 34:604–613.
   Google Scholar
• Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1946–1949.
   PubMed Web of Science ®Google Scholar
• Di S, Malcher-Lopes R, Halmos KC, Tasker JG. 2003. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. J Neurosci. 23:4850–4857.
   PubMed Web of Science ®Google Scholar
• Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:686–691.
   PubMed Web of Science ®Google Scholar
• Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA. 99:10819–10824.
   PubMed Web of Science ®Google Scholar
• Egertová M, Giang DK, Cravatt BF, Elphick MR. 1998. A new perspective on cannabinoid signaling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci. 265:2081–2085.
   PubMed Web of Science ®Google Scholar
• Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP. 2010. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology. 151:1–9.
   PubMedGoogle Scholar
• Finn DP. 2010. Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance. Immunobiology. 215:629–646.
   PubMed Web of Science ®Google Scholar
• Finn DP, Beckett SRG, Richardson D, Kendall DA, Marsden CA, Chapman V. 2004. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur J Neurosci. 20:848–852.
   PubMedGoogle Scholar
• Ford GK, Finn DP. 2008. Clinical correlates of stress-induced analgesia: Evidence from pharmacological studies. Pain. 140:3–7.
   PubMedGoogle Scholar
• Ganon-Elazar E, Akirav I. 2009. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci. 29:11078–11088.
   PubMedGoogle Scholar
• Ginsberg AB, Pecoraro NC, Warne JP, Horneman HF, Dallman MF. 2010. Rapid alterations of stress-induced hypothalamic–pituitary–adrenal hormone secretion in the rat: A comparison of glucocorticoids and cannabinoids. Stress. 13:248–257.
   PubMed Web of Science ®Google Scholar
• Goani Y, Mechoulam R. 1964. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc. 86:1646–1647.
   Google Scholar
• Goparaju SK, Ueda N, Taniguchi K, Yamamoto S. 1999. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol. 57:417–423.
   PubMed Web of Science ®Google Scholar
• Gorzalka BB, Hill MN, Hillard CJ. 2008. Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders. Neurosci Biobehav Rev. 32:1152–1160.
   PubMed Web of Science ®Google Scholar
• Grissom N, Bhatnagar S. 2009. Habituation to repeated stress: Get used to it. Neurobiol Learn Mem. 92:215–224.
   PubMed Web of Science ®Google Scholar
• Haller J, Varga B, Ledent C, Barna I, Freund TF. 2004. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci. 19:1906–1912.
   PubMed Web of Science ®Google Scholar
• Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R. 2001. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA. 98:3662–3665.
   PubMed Web of Science ®Google Scholar
• Harloe JP, Thorpe AJ, Lichtman AH. 2008. Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks. Learn Mem. 15:806–809.
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1990. Cannabinoid receptor localization in the brain. Proc Natl Acad Sci USA. 87:1932–1936.
   PubMed Web of Science ®Google Scholar
• Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci. 11:563–583.
   PubMed Web of Science ®Google Scholar
• Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. 2003. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness. Front Neuroendocrinol. 24:151–180.
   PubMed Web of Science ®Google Scholar
• Herman JP, Ostrander MM, Mueller NK, Figueiredo H. 2005. Limbic system mechanisms of stress regulation: Hypothalamo–pituitary–adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry. 29:1201–1213.
   PubMed Web of Science ®Google Scholar
• Hill MN, Gorzalka BB. 2004. Enhancement of anxiety-like responsiveness to the cannabinoid receptor agonist HU-210 following chronic stress. Eur J Pharmacol. 499:291–295.
   PubMed Web of Science ®Google Scholar
• Hill MN, Gorzalka BB. 2005. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav Pharmacol. 16:333–352.
   PubMed Web of Science ®Google Scholar
• Hill MN, McEwen BS. 2009. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci USA. 106:4579–4580.
   PubMed Web of Science ®Google Scholar
• Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. 2005. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 30:508–515.
   PubMed Web of Science ®Google Scholar
• Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol Sci. 2009a; 30:484–493.
   PubMed Web of Science ®Google Scholar
• Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic–pituitary–adrenal axis. Neuropsychopharmacology. 2009b; 34:2733–2745.
   PubMed Web of Science ®Google Scholar
• Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 2010a; 35:1333–1338.
   PubMed Web of Science ®Google Scholar
• Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TTY, Gray JM, Hillard CJ, Gorzalka BB, Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci USA. 2010b; 107:9406–9411.
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Harris RA, Bloom AS. 1985. Effects of cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies. J Pharmacol Exp Ther. 232:579–588.
   PubMed Web of Science ®Google Scholar
• Hinz B, Hirschelmann R. 2000. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm Res. 17:1273–1277.
   PubMed Web of Science ®Google Scholar
• Hohmann AG, Suplita RL. 2006. Endocannabinoid mechanisms of pain modulation. AAPS J. 8:E693–E708.
   PubMed Web of Science ®Google Scholar
• Hölter SM, Kallnik M, Wurst W, Marsicano G, Lutz B, Wotjak CT. 2005. Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task. 2005. Eur J Pharmacol. 7:69–74.
   Google Scholar
• Howlett AC. 1987. Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana. Neuropharmacology. 26:507–512.
   PubMedGoogle Scholar
• Howlett AC, Fleming RM. 1984. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol. 26:532–538.
   PubMed Web of Science ®Google Scholar
• Jacob W, Yassouridis A, Marsicano G, Monory K, Lutz B, Wotjak CT. 2009. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: Role of glutamatergic transmission. Genes Brain Behav. 8:685–698.
   PubMedGoogle Scholar
• Kamprath K, Wotjak CT. 2004. Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn Mem. 11:770–786.
   PubMedGoogle Scholar
• Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT. 2006. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci. 26:6677–6686.
   PubMed Web of Science ®Google Scholar
• Kamprath K, Plendl W, Marsicano G, Deussing JM, Wurst W, Lutz B, Wotjak CT. 2009. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav. 8:203–211.
   PubMedGoogle Scholar
• Kamprath K, Romo-Parra H, Häring M, Gaburro S, Doengi M, Lutz B, Pape H. 2010. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology. 36:652–663.
   PubMedGoogle Scholar
• Kant GJ, Eggleston T, Landman-Roberts L, Kenion CC, Driver GC, Meyerhoff JL. 1985. Habituation to repeated stress is stressor specific. Pharmacol Biochem Behav. 22:631–634.
   PubMed Web of Science ®Google Scholar
• Karst H, Berger S, Erdmann G, Schütz G, Joëls M. 2010. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci USA. 107:14449–14454.
   PubMedGoogle Scholar
• Keller-Wood ME, Dallman MF. 1984. Corticosterone inhibition of ACTH secretion. Endocr Rev. 5:1–24.
   PubMed Web of Science ®Google Scholar
• Koolhaas JM, Bartolomucci A, Buwalda B, de Boer SF, Flügge G, Korte SM, Meerlo P, Murison R, Oliver B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, van Dijk G, Wöhr M, Fuchs E. 2011. Stress revisited: A critical evaluation of the stress concept. Neurosci Biobehav Rev. 35:1291–1301.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Han M, Graham DL, Berton O, Renthal W, Russo SJ, LaPlant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ. 2007. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 131:391–404.
   PubMed Web of Science ®Google Scholar
• Lazarus RS. 1966. Psychological stress and the coping process. New York: McGraw-Hill.
   Google Scholar
• Lazarus RS, Launier R. 1978. Stress-related transactions between person and environment. In: Pervin LA, Lewis M. editors. Perspectives in interactional psychology. New York: Plenum287–327.
   Google Scholar
• Lazarus RS, Folkman S. 1984. Stress, appraisal, and coping. New York: Springer.
   Google Scholar
• Leggett JD, Aspley S, Beckett SRG, D'Atona AM, Kendall DA, Kendall DA. 2004. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol. 141:253–262.
   PubMed Web of Science ®Google Scholar
• Lovinger DM. 2007. Endocannabinoid liberation from neurons in transsynaptic signaling. J Mol Neurosci. 33:87–93.
   PubMedGoogle Scholar
• Mackie K, Hille B. 1992. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA. 89:3825–3829.
   PubMed Web of Science ®Google Scholar
• Mackie K, Lai Y, Westenbroek R, Mitchell R. 1995. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci. 15:6552–6561.
   PubMed Web of Science ®Google Scholar
• Macrì S, Laviola G. 2004. Single episode of maternal deprivation and adult depressive profile in mice: Interaction with cannabinoid exposure during adolescence. Behav Brain Res. 154:231–238.
   PubMedGoogle Scholar
• Malcher-Lopes R, Di S, Marcheselli VS, Weng F, Stuart CT, Bazan NG, Tasker JG. 2006. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci. 26:6643–6650.
   PubMed Web of Science ®Google Scholar
• Marco EM, Adriani A, Llorente R, Laviola G, Viveros M. 2009. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: Altered responses to cannabinoid exposure. Neurosci Biobehav Rev. 33:498–507.
   PubMedGoogle Scholar
• Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B. 2002. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 418:530–534.
   PubMed Web of Science ®Google Scholar
• Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. 2002. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology. 159:379–387.
   PubMed Web of Science ®Google Scholar
• Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:561–564.
   PubMed Web of Science ®Google Scholar
• McEwen BS. 1998. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 840:33–44.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Wingfield JC. 2003. The concept of allostasis in biology and biomedicine. Horm Behav. 43:2–15.
   PubMed Web of Science ®Google Scholar
• Mikics É, Dombi T, Barsvári B, Varga B, Ledent C, Freund TF, Haller J. 2006. The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav Pharmacol. 17:223–230.
   PubMedGoogle Scholar
• Moreira FA, Wotjak CT. 2010. Cannabinoids and anxiety. Curr Top Behav Neurosci. 2:429–450.
   PubMedGoogle Scholar
• Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:61–65.
   PubMed Web of Science ®Google Scholar
• Natelson BH, Ottenweller JE, Cook JA, Pitman D, McCarty R, Tapp WN. 1988. Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol Behav. 43:41–46.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo A, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM, STRADIVARIUS Investigators. 2008. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial. J Am Med Assoc. 299:1547–1560.
   PubMed Web of Science ®Google Scholar
• Niyuhire F, Varvel SA, Thorpe AJ, Stokes RJ, Wiley JL, Lichtman AH. 2007. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology. 191:223–231.
   PubMedGoogle Scholar
• Pamplona FA, Bitencourt RM, Takahashi RN. 2008. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiol Learn Mem. 90:290–293.
   PubMed Web of Science ®Google Scholar
• Patel S, Hillard CJ. 2008. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: A novel mechanism for stress habituation. Eur J Neurosci. 27:2821–2829.
   PubMedGoogle Scholar
• Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. 2004. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic–pituitary–adrenal axis. Endocrinology. 145:5431–5438.
   PubMed Web of Science ®Google Scholar
• Patel S, Roelke CT, Rademacher DJ, Hillard CJ. 2005. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signaling. Eur J Neurosci. 21:1057–1069.
   PubMed Web of Science ®Google Scholar
• Patel S, Kingsley PJ, Mackie K, Marnett LJ, Winder DG. 2009. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuroppsychopharmacology. 34:2699–2709.
   PubMed Web of Science ®Google Scholar
• Pecoraro N, Dallman MF, Warne JP, Ginsberg AB, Laugero KD, la Fleur SE, Houshyar H, Gomez F, Bhargava A, Akana SF. 2006. From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants. Prog Neurobiol. 79:247–340.
   PubMedGoogle Scholar
• Piomelli D. 2003. The molecular logic of endocannabinoid signaling. Nat Rev Neurosci. 4:873–884.
   PubMed Web of Science ®Google Scholar
• Plendl W, Wotjak CT. 2010. Dissociation of within- and between-session extinction of conditioned fear. J Neurosci. 30:4990–4998.
   PubMedGoogle Scholar
• Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC. 2002. Characterization of a novel endocannabinoid, Virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther. 301:1020–1024.
   PubMed Web of Science ®Google Scholar
• Rademacher DJ, Hillard CJ. 2007. Interactions between endocannbinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry. 31:633–641.
   PubMedGoogle Scholar
• Rademacher DJ, Meier SE, Shi L, Ho WSV, Jarrahian A, Hillard CJ. 2008. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology. 54:108–116.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Dalvi A. 1997. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev. 21:801–810.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Haller J, Holmes A, Halasz J, Walton TJ, Brain PF. 1999. Corticosterone response to the plus-maze: High correlation with risk assessment in rats and mice. Physiol Behav. 68:47–53.
   PubMed Web of Science ®Google Scholar
• Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D. 2008. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci. 28:7284–7292.
   PubMed Web of Science ®Google Scholar
• Selye H. 1950. Stress and the general adaptation syndrome. Br Med J. 4667:1383–1392.
   Google Scholar
• Sousa N, Almeida OF, Wotjak CT. 2006. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav. 5 Suppl. 2: 5–24.
   PubMedGoogle Scholar
• Steiner MA, Wotjak CT. 2008. Role of the endocannabinoid system in regulation of the hypothalamic–pituitary–adrenocortical axis. Prog Brain Res. 170:397–432.
   PubMed Web of Science ®Google Scholar
• Steiner MA, Marsicano G, Nestler EJ, Holsboer F, Lutz B, Wotjak CT. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology. 2008a; 33:54–67.
   PubMedGoogle Scholar
• Steiner MA, Marsicano G, Wotjak CT, Lutz B. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology. 2008b; 33:1165–1170.
   PubMed Web of Science ®Google Scholar
• Stella N, Schweitzer P, Piomelli D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:773–778.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 1995. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 215:89–97.
   PubMed Web of Science ®Google Scholar
• Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhibition of the HPA axis. Stress. 2011 in press.
   PubMedGoogle Scholar
• Tasker JG, Di S, Malcher-Lopes R. 2006. Minireview: Rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology. 147:5549–5556.
   PubMed Web of Science ®Google Scholar
• Thoeringer CK, Pfeiffer UJ, Rammes G, Pamplona FA, Moosmang S, Wotjak CT. 2010. Early life environment determines the development of adult phobic-like fear responses in BALB/cAnN mice. Genes Brain Behav. 9:947–957.
   PubMedGoogle Scholar
• Thompson RF, Spencer WA. 1966. Habituation: A model phenomenon for the study of neuronal substrates of behaviour. Psychol Rev. 73:16–43.
   PubMed Web of Science ®Google Scholar
• Tsigos C, Chrousos GP. 2002. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 53:865–871.
   PubMed Web of Science ®Google Scholar
• Twitchell W, Brown S, Mackie K. 1997. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol. 78:43–50.
   PubMed Web of Science ®Google Scholar
• Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA. 2005. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 310:329–332.
   PubMed Web of Science ®Google Scholar
• Wamsteeker JI, Kuzmiski JB, Bains JS. 2010. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci. 30:1118–11196.
   PubMedGoogle Scholar
• Willner P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology. 134:319–329.
   PubMed Web of Science ®Google Scholar
• Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. 1987. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by tricyclic antidepressant. Psychopharmacology. 93:358–364.
   PubMed Web of Science ®Google Scholar